IL-1 blocking agents are used to treat various rheumatic diseases such as rheumatoid arthritis (RA) and autoinflammatory disorders such as familial Mediterranean fever (FMF), gout, adult-onset Still’s disease, and systemic-onset juvenile idiopathic arthritis [88–90]. Here, IL1A is linked to familial Mediterranean fever.